MedTrace Logo

Improving Primary Care After Stroke (IPCAS)

NCT03353519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1041

Last updated 2021-10-07

No results posted yet for this study

Summary

No formal primary care based model of care exists to support stroke survivors living in the community. A large variation in the range, quality and access to health services offered to stroke survivors between and within local clinical commissioning groups suggests that many of the stroke survivors' needs are not being met systematically. Therefore, to address the longer term needs we have developed a multi-factorial primary care model that seeks to enable greater engagement with stroke care and community services, to link effectively to specialist services, and to improve the lives of stroke survivors.

This will be a two-arm cluster randomised controlled trial. Participating general practices will be randomised to deliver either the new model of stroke care or current usual care. The aim of this trial will be to assess the clinical and long-term cost effectiveness of the new model of primary care for stroke survivors living in the community. The primary outcome for the trial will be measured using two sub-scales (emotion and handicap) of the Stroke Impact Scale questionnaire at 12 months.

Conditions

Interventions

OTHER

Primary care model

Specifically, the intervention will comprise the following components: 1. Structured review of patient needs; 2. A self-management programme (MLAS) for stroke survivors and their carers; 3. A direct point of contact for stroke survivors and carers at the GP surgery; 4. Optimised communication between General Practice staff and specialist services; 5. Service mapping for stroke related needs; 6. Training for General Practice staff.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03353519 on ClinicalTrials.gov